日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer

非小细胞肺癌和小细胞肺癌免疫状态的多样性和异质性

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0260988
Rice, Shawn J; Belani, Chandra P
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic

2019冠状病毒病大流行期间肺癌患者的治疗指南

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2020.05.001
Dingemans, Anne-Marie C; Soo, Ross A; Jazieh, Abdul Rahman; Rice, Shawn J; Kim, Young Tae; Teo, Lynette L S; Warren, Graham W; Xiao, Shu-Yuan; Smit, Egbert F; Aerts, Joachim G; Yoon, Soon Ho; Veronesi, Giulia; De Cobelli, Francesco; Ramalingam, Suresh S; Garassino, Marina C; Wynes, Murry W; Behera, Madhusmita; Haanen, John; Lu, Shun; Peters, Solange; Ahn, Myung-Ju; Scagliotti, Giorgio V; Adjei, Alex A; Belani, Chandra P
微生物学
肺癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury

电子烟或雾化相关肺损伤的临床管理指南

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2020.08.012
Rice, Shawn J; Hyland, Victoria; Behera, Madhusmita; Ramalingam, Suresh S; Bunn, Paul; Belani, Chandra P
发表日期：2020
文献求助 收藏

EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer.

EGFR 突变和 AKT 磷酸化是 MCL-1 和 BCL-2/xL 联合抑制治疗对非小细胞肺癌敏感性的标志

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0217657
Rice Shawn J, Liu Xin, Wang Hong-Gang, Belani Chandra P
细胞生物学
肺癌
EGFR
磷酸化
发表日期：2019
文献求助 收藏

Membrane trafficking and exocytosis are upregulated in port wine stain blood vessels

葡萄酒色斑血管中膜转运和胞吐作用上调。

期刊:Histology and Histopathology
影响因子:2
doi:10.14670/HH-18-051
Yin, Rong; Rice, Shawn J; Wang, Jinwei; Gao, Lin; Tsai, Joseph; Anvari, Radean T; Zhou, Fang; Liu, Xin; Wang, Gang; Tang, Yuxin; Mihm, Martin C Jr; Belani, Chandra P; Chen, Dong-Bao; Nelson, J Stuart; Tan, Wenbin
发表日期：2019
文献求助 收藏

Trametinib with or without vemurafenib in BRAF mutated non-small cell lung cancer

BRAF突变型非小细胞肺癌患者接受曲美替尼联合或不联合维莫非尼治疗

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0118210
Joshi, Monika; Rice, Shawn J; Liu, Xin; Miller, Bruce; Belani, Chandra P
肺癌
肿瘤
肿瘤免疫
BRAF
细胞生物学
发表日期：2015
文献求助 收藏

Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)

Occludin 是甲状腺转录因子-1 (TTF-1/NKX2-1) 的直接靶标。

期刊:Journal of Biological Chemistry
影响因子:3.9
doi:10.1074/jbc.M112.367987
Runkle, E Aaron; Rice, Shawn J; Qi, Ji; Masser, Dustin; Antonetti, David A; Winslow, Monte M; Mu, David
Occludin
免疫/内分泌
发表日期：2012
文献求助 收藏